Retinal pigment epithelial tear after intravitreal bevacizumab injection for exudative age-related macular degeneration

Retinal pigment epithelial tear after intravitreal bevacizumab injection for exudative age-related macular degeneration

Bibliographic Details
Main Authors:	Sunil Kumar Singh, Satyen Deka
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-01-01
Series:	Oman Journal of Ophthalmology
Online Access:	http://www.ojoonline.org/article.asp?issn=0974-620X;year=2014;volume=7;issue=2;spage=104;epage=106;aulast=Singh

Similar Items

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration
by: Shaikh Saad, et al.
Published: (2007-01-01)

Effect of intravitreal aflibercept injection for age-related macular degeneration with a retinal pigment epithelial tear refractory to intravitreal ranibizumab injection
by: Fujii A, et al.
Published: (2014-06-01)

Spontaneous or secondary to intravitreal injections of anti-angiogenic agents retinal pigment epithelial tears in age-related macular degeneration
by: Pia E. Leon, et al.
Published: (2014-08-01)

Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion
by: Satyen Deka, et al.
Published: (2009-01-01)

Intravitreal gas injection with prone positioning for giant retinal pigment epithelial tear
by: Deependra Vikram Singh, et al.
Published: (2018-01-01)

Treatment of retinal pigment epithelial detachment secondary to exudative age-related macular degeneration
by: Andres Gonzalez, et al.
Published: (2018-03-01)

Intravitreal bevacizumab for pediatric exudative retinal diseases
by: Abdelrahman G. Salman, MD, FRCS
Published: (2011-04-01)

Intravitreal injection of Conbercept in the treatment of exudative age-related macular degeneration
by: Hong-Xia Niu, et al.
Published: (2018-09-01)

Retinal pigment epithelial tears following treatment in neovascular age-related macular degeneration
by: Zhi-Qing Chen, et al.
Published: (2016-03-01)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
by: Jeon S, et al.
Published: (2014-08-01)

Retinal pigment epithelium tear after intravitreal aflibercept injection
by: Saito M, et al.
Published: (2013-06-01)

Spectral domain optical coherence tomography features of multiple subfoveal retinal pigment epithelial tears after intravitreal bevacizumab
by: Chalam Kakarla, et al.
Published: (2011-01-01)

Intravitreal injection of Bevacizumab combined retinal photocoagulation for diabetic macular edema
by: Quan-Liang Zhao, et al.
Published: (2013-08-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

Clinical observation of intravitreal injection of Conbercept treating exudative age-related macular degeneration
by: Wei Song, et al.
Published: (2016-07-01)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
by: Elad Moisseiev, et al.
Published: (2010-08-01)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
by: R Prince Davis, et al.
Published: (2010-06-01)

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
by: Suzuki H, et al.
Published: (2017-08-01)

Intravitreal bevacizumab injection in the treatment of macular edema secondary to branch retinal vein occlusion
by: Şeref İstek, et al.
Published: (2014-06-01)

Retinal Pigment Epithelial Detachment in Age-Related Macular Degeneration
by: Michael Karampelas, et al.
Published: (2020-08-01)

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
by: Hamidreza Torabi, et al.
Published: (2018-01-01)

Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment
by: Marcus Werner Storch, et al.
Published: (2017-01-01)

Prospective Study of Vessel Density by Optical Coherence Tomography Angiography After Intravitreal Bevacizumab in Exudative Age-Related Macular Degeneration
by: Gilda Cennamo, et al.
Published: (2019-10-01)

Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
by: Umut Karaca, et al.
Published: (2012-01-01)

Changes in retinal nerve fiber layer thickness after two intravitreal bevacizumab injections for wet type age-related macular degeneration
by: Morteza Entezari, et al.
Published: (2014-01-01)

Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration
by: Moosang Kim, et al.
Published: (2016-01-01)

Comment on: “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”
by: Koushik Tripathy
Published: (2018-01-01)

THE MACULAR HOLE AFTER INTRAVITREAL INJECTIONS OF RANIBIZUMAB IN A PATIENT WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION – A CASE STUDY
by: Magdalena Kal, et al.
Published: (2013-11-01)

Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Correlation with Macular Function
by: Maria C. Savastano, et al.
Published: (2020-09-01)

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
by: Mohamed A. Hamid, et al.
Published: (2021-04-01)

Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
by: Joel Hanhart, et al.
Published: (2017-10-01)

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
by: Ramin Nourinia, et al.
Published: (2010-01-01)

Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections
by: Yong Un Shin, et al.
Published: (2017-10-01)

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
by: Mohammad Riazi-Esfahani, et al.
Published: (2008-12-01)

Ganglion Cell Complex Evaluation in Exudative Age-Related Macular Degeneration after Repeated Intravitreal Injections of Ranibizumab
by: Andrea Perdicchi, et al.
Published: (2015-01-01)

Serpentine retinal pigment epithelial tear
by: Aditya Maitray, et al.
Published: (2021-01-01)

Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
by: Panos GD, et al.
Published: (2013-07-01)

Initial Dose of Three Monthly Intravitreal Injections versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Seong Joon Ahn, et al.
Published: (2013-01-01)

Response to comment on “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”
by: Marcus Storch, et al.
Published: (2018-01-01)

Macular Edema Formation and Deterioration of Retinal Function after Intravitreal Bevacizumab Injection for Proliferative Diabetic Retinopathy
by: Hisanori Imai, et al.
Published: (2011-09-01)

Cannot write session to /tmp/vufind_sessions/sess_qoddvupu39frp3eb4cuh7ft0fa